REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 87 filers reported holding REATA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,444,366 | +446.5% | 14,166 | +387.3% | 0.00% | – |
| Q1 2023 | $264,304 | -96.4% | 2,907 | -99.0% | 0.00% | -100.0% |
| Q3 2022 | $7,410,000 | -61.5% | 294,889 | -53.5% | 0.00% | -60.0% |
| Q2 2022 | $19,257,000 | -31.0% | 633,656 | -25.6% | 0.01% | -9.1% |
| Q1 2022 | $27,917,000 | +24.2% | 852,158 | -0.0% | 0.01% | +37.5% |
| Q4 2021 | $22,474,000 | -78.2% | 852,263 | -16.8% | 0.01% | -79.5% |
| Q3 2021 | $103,054,000 | -47.5% | 1,024,298 | -26.2% | 0.04% | -48.0% |
| Q2 2021 | $196,438,000 | +35.0% | 1,387,960 | -4.9% | 0.08% | +27.1% |
| Q1 2021 | $145,541,000 | -19.5% | 1,459,789 | -0.1% | 0.06% | -22.4% |
| Q4 2020 | $180,724,000 | +33.1% | 1,461,927 | +4.9% | 0.08% | +15.2% |
| Q3 2020 | $135,770,000 | -36.2% | 1,393,654 | +4.5% | 0.07% | -40.0% |
| Q2 2020 | $212,772,000 | +22.6% | 1,333,081 | +10.9% | 0.11% | -5.2% |
| Q1 2020 | $173,545,000 | -31.7% | 1,201,871 | -3.3% | 0.12% | -13.4% |
| Q4 2019 | $254,131,000 | +152.2% | 1,243,131 | -0.9% | 0.13% | +143.6% |
| Q3 2019 | $100,766,000 | -7.8% | 1,255,027 | +8.3% | 0.06% | -5.2% |
| Q2 2019 | $109,326,000 | +30.7% | 1,158,730 | +18.4% | 0.06% | +28.9% |
| Q1 2019 | $83,652,000 | +55.1% | 978,736 | +1.8% | 0.04% | +36.4% |
| Q4 2018 | $53,929,000 | -23.2% | 961,299 | +11.9% | 0.03% | -5.7% |
| Q3 2018 | $70,233,000 | +656.6% | 859,013 | +223.6% | 0.04% | +600.0% |
| Q2 2018 | $9,283,000 | +70.5% | 265,461 | +0.0% | 0.01% | +66.7% |
| Q1 2018 | $5,444,000 | -27.6% | 265,434 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $7,517,000 | -3.3% | 265,434 | +6.2% | 0.00% | 0.0% |
| Q3 2017 | $7,776,000 | – | 250,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |